Literature DB >> 10895807

Treatment of refractory interstitial cystitis.

A Morales1, L Emerson, J C Nickel.   

Abstract

Interstitial cystitis is the most therapeutically frustrating condition of the urinary tract. The vast array of treatments available clearly indicates that none is particularly effective. As the majority of patients fail to experience a significant and prolonged response to standard treatments, new options are frequently being developed. These include the oral administration of cimetidine, the intravesical use of hyaluronic acid and BCG, and total cystectomy with the formation of a continent urinary diversion. Unfortunately, the acceptance of many new treatments is based on incomplete evaluation, and this has resulted in a confusing array of disparate alternatives. Effective and durable treatment will not be available until the nature of the disease is better understood and the mechanisms of action of current therapies are elucidated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 10895807     DOI: 10.1007/BF01907075

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  33 in total

1.  Conservative therapy of interstitial cystitis.

Authors:  P M Hanno; A J Wein
Journal:  Semin Urol       Date:  1991-05

2.  The bladder mucus (glycosaminoglycan) layer in interstitial cystitis.

Authors:  J C Nickel; L Emerson; J Cornish
Journal:  J Urol       Date:  1993-04       Impact factor: 7.450

3.  Nalmefene in the treatment of interstitial cystitis.

Authors:  N N Stone
Journal:  Urol Clin North Am       Date:  1994-02       Impact factor: 2.241

4.  Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis).

Authors:  C L Parsons; J D Lilly; P Stein
Journal:  J Urol       Date:  1991-04       Impact factor: 7.450

5.  Dose-response of bacillus Calmette-Guerin in the treatment of superficial bladder cancer.

Authors:  A Morales; J C Nickel; J W Wilson
Journal:  J Urol       Date:  1992-05       Impact factor: 7.450

6.  Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study.

Authors:  S G Mulholland; P Hanno; C L Parsons; G R Sant; D R Staskin
Journal:  Urology       Date:  1990-06       Impact factor: 2.649

7.  A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate.

Authors:  C L Parsons; G Benson; S J Childs; P Hanno; G R Sant; G Webster
Journal:  J Urol       Date:  1993-09       Impact factor: 7.450

8.  Interstitial cystitis, treated by prolonged bladder distension.

Authors:  M Dunn; P D Ramsden; J B Roberts; J C Smith; P J Smith
Journal:  Br J Urol       Date:  1977

Review 9.  Transcutaneous electrical nerve stimulation in classic and nonulcer interstitial cystitis.

Authors:  M Fall; S Lindström
Journal:  Urol Clin North Am       Date:  1994-02       Impact factor: 2.241

10.  The fate of the defunctioned bladder following supravesical urinary diversion.

Authors:  A B Adeyoju; J Thornhill; T Lynch; R Grainger; T McDermott; M R Butler
Journal:  Br J Urol       Date:  1996-07
View more
  5 in total

1.  The pain of interstitial cystitis.

Authors:  P L Dwyer; A Rosamilia
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

Review 2.  Interstitial cystitis. Etiology, diagnosis, and treatment.

Authors:  J C Nickel
Journal:  Can Fam Physician       Date:  2000-12       Impact factor: 3.275

3.  Interstitial cystitis: characterization and management of an enigmatic urologic syndrome.

Authors:  J Curtis Nickel
Journal:  Rev Urol       Date:  2002

Review 4.  Resiniferatoxin in the treatment of interstitial cystitis: a systematic review.

Authors:  Eleni G Mourtzoukou; Christos Iavazzo; Matthew E Falagas
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-06-19

5.  Intravesical hyaluronic acid and chondroitin sulphate for bladder pain syndrome/interstitial cystitis: long-term treatment results.

Authors:  M Cervigni; F Natale; L Nasta; A Mako
Journal:  Int Urogynecol J       Date:  2012-05-09       Impact factor: 2.894

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.